uvstocks.io

Today’s CSR movers

FOX 3.9 ▲ 1.5

CMCSA 3.1 ▲ 0.8

VTRS 3.9 ▲ 0.3

KMI 3.3 ▼ 0.4

ES 2.2 ▼ 0.8

SO 2.3 ▼ 0.8

ETR 2.9 ▼ 1.2

AEE 2.8 ▼ 1.2

PCG 2.9 ▼ 1.2

CMS 2.6 ▼ 1.3

Health Care · NYSE NYSE · IQV

IQVIA

$208.05 +$0.73 +0.35% CLOSE 07.24.26 AFTER HOURS $209.00

Convergence score

4.2 / 5.0 STRONG BULLISH

+0.1 vs last report

Overall valuation

Fairly Valued

Aggregated across multiple horizons

Consensus target (12mo)

$229.90 +10.5%

Range $185.00 — $284.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 07.24.26

UV Convergence Score

REPORT 07.24.26

4.2

/ 5.0

STRONG BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Rating trend signal

4.6

Analyst average

4.5

Multi-signal aggregate How CSR works →

Day Range

$206.97 – $209.99

52W Range

$154.50 – $247.05

Volume

888.1K

Avg Vol

1.6M

Mkt Cap

$34.72B

P/E

25.88

EPS (TTM)

$8.04

Div Yield

—

Beta

1.20

Today's convergence

Convergence score sits at 4.2 with overall valuation reading as fairly valued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Fairly Valued

CSR direction

STRONG BULLISH

Last close

$208.05

Sector

Health Care

Valuation

Three horizons

UPDATED 07.24.26

Short term

0–3 MO

No target Strong Buy

Medium term

3–12 MO

$226+8.5% Buy

Long term

12–36 MO

$221.59+6.5% Fairly Valued

Open valuation →

Analysts

Coverage & consensus

4 PANELS

Mean target (12mo)

$229.90 +10.5%

RANGE $185.00 — $284.00

Analyst consensus

Consensus rating Strong Buy

Blended score 4.5 / 5

Analysts tracked 78

Open analysts →

Financials

Key metrics

LATEST

P/E

25.88

EPS (TTM)

$8.04

Mkt Cap

$34.72B

Div Yield

—

Beta

1.20

52W Range

$154.50 – $247.05

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 07.24.26

Short term

0–3 MO

Strong Buy

Consensus target

No target available

Current analyst consensus rating from Barchart.

Medium term

3–12 MO

Buy

Consensus target

$226 +8.5%

RANGE $185 – $255

$185NOW $208.05$255

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Fairly Valued

Consensus target

$221.59 +6.5%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 25.88	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $2.28B	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.24.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Strong Buy 4.5 4 78

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $185.00 $229.90 $230.00 $284.00 +10.5%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 4 28 6 0 0

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current Strong Buy 4.57 21

1 Mo Ago Strong Buy 4.62 21

2 Mo Ago Strong Buy 4.64 22

3 Mo Ago Strong Buy 4.64 22

Most recent analyst action LATEST DESK ACTION

Date

7/15/2026

Firm

Weiss Ratings

Action

Upgrade

Rating

Hold (C-) ➝ Hold (C)

Target

—

Full financial snapshot.

UPDATED 07.24.26

Quote snapshot 15 FIELDS

Prev Close

$207.32

Open

$208.14

Day Low

$206.97

Day High

$209.99

Bid

$200.00

Ask

$222.83

52W Low

$154.50

52W High

$247.05

50D Avg

$186.92

200D Avg

$196.59

Volume

888.1K

Avg Vol

1.6M

10D Avg Vol

1.1M

52W Change

4.09%

S&P 52W Change

15.96%

Valuation ratios 10 FIELDS

P/E (TTM)

25.88

P/E (Fwd)

14.68

PEG (Fwd)

0.84

P/S

2.09

P/B

5.58

Book Value

$37.27

EV/Revenue

2.93

EV/EBITDA

16.24

Mkt Cap

34.72B

Enterprise Val

48.72B

Profitability & returns 6 FIELDS

Profit Margin

8.33%

Gross Margin

32.99%

Operating Margin

13.61%

EBITDA Margin

18.04%

Return on Assets

5.13%

Return on Equity

22.49%

Growth 3 FIELDS

Revenue Growth (YoY)

8.40%

Earnings Growth (YoY)

15.00%

Earnings Growth (Q)

10.00%

Balance sheet & cash flow 11 FIELDS

Total Revenue

16.63B

EBITDA

Total Cash

2.1B

Total Debt

16.1B

Cash / Share

$12.60

Revenue / Share

$97.79

Free Cash Flow

2.28B

Operating CF

2.7B

Debt / Equity

253.54

Current Ratio

0.75

Quick Ratio

0.66

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

—

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

—

Share statistics 7 FIELDS

Shares Out

166.9M

Float

158.55M

Shares Short

4.98M

% Short of Float

3.45%

Short Ratio

3.06

% Held Insiders

1.08%

% Held Institutions

103.94%

Calendar & events 5 FIELDS

Next Earnings

2026-07-28

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-03-31

Last Split

—

Split Date

—

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

93,000